ALMA RITSEMA: Open Payments
NPI 1205995743 · APTOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 14 payments from 5 companies in 2025. Trend: 2023 $120 · 2024 $47 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $205 |
| Axsome Therapeutics, Inc. | 3 | $148 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Alkermes, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
Products named: VRAYLAR, Auvelity, REXULTI, LYBALVI, FANAPT.
Industry payments across CA — which companies pay providers there.
